These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

788 related items for PubMed ID: 15978265

  • 1. Serum BAP as the clinically useful marker for predicting BMD reduction in diabetic hemodialysis patients with low PTH.
    Ueda M, Inaba M, Okuno S, Maeno Y, Ishimura E, Yamakawa T, Nishizawa Y.
    Life Sci; 2005 Jul 22; 77(10):1130-9. PubMed ID: 15978265
    [Abstract] [Full Text] [Related]

  • 2. Clinical usefulness of the serum N-terminal propeptide of type I collagen as a marker of bone formation in hemodialysis patients.
    Ueda M, Inaba M, Okuno S, Nagasue K, Kitatani K, Ishimura E, Shimizu M, Miki T, Kim M, Nishizawa Y.
    Am J Kidney Dis; 2002 Oct 22; 40(4):802-9. PubMed ID: 12324916
    [Abstract] [Full Text] [Related]

  • 3. Increased bone turnover in late postmenopausal women is a major determinant of osteoporosis.
    Garnero P, Sornay-Rendu E, Chapuy MC, Delmas PD.
    J Bone Miner Res; 1996 Mar 22; 11(3):337-49. PubMed ID: 8852944
    [Abstract] [Full Text] [Related]

  • 4. Serum pyridinoline as a specific marker of collagen breakdown and bone metabolism in hemodialysis patients.
    Ureña P, Ferreira A, Kung VT, Morieux C, Simon P, Ang KS, Souberbielle JC, Segre GV, Drüeke TB, De Vernejoul MC.
    J Bone Miner Res; 1995 Jun 22; 10(6):932-9. PubMed ID: 7572317
    [Abstract] [Full Text] [Related]

  • 5. Cross-sectional evaluation of bone metabolism in men.
    Szulc P, Garnero P, Munoz F, Marchand F, Delmas PD.
    J Bone Miner Res; 2001 Sep 22; 16(9):1642-50. PubMed ID: 11547833
    [Abstract] [Full Text] [Related]

  • 6. Body mass index (BMI) and parameters of bone formation and resorption in postmenopausal women.
    Papakitsou EF, Margioris AN, Dretakis KE, Trovas G, Zoras U, Lyritis G, Dretakis EK, Stergiopoulos K.
    Maturitas; 2004 Mar 15; 47(3):185-93. PubMed ID: 15036488
    [Abstract] [Full Text] [Related]

  • 7. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH, Huang TS, Hsieh SJ.
    Miner Electrolyte Metab; 1996 Mar 15; 22(4):219-23. PubMed ID: 8807625
    [Abstract] [Full Text] [Related]

  • 8. Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.
    Inaba M, Okuno S, Imanishi Y, Ueda M, Yamakawa T, Ishimura E, Nishizawa Y.
    Osteoporos Int; 2005 May 15; 16(5):517-25. PubMed ID: 15322741
    [Abstract] [Full Text] [Related]

  • 9. Relationship of bone turnover to bone density and fractures.
    Melton LJ, Khosla S, Atkinson EJ, O'Fallon WM, Riggs BL.
    J Bone Miner Res; 1997 Jul 15; 12(7):1083-91. PubMed ID: 9200008
    [Abstract] [Full Text] [Related]

  • 10. Serum levels of C-terminal telopeptide of type I collagen: a useful new marker of cortical bone loss in hemodialysis patients.
    Okuno S, Inaba M, Kitatani K, Ishimura E, Yamakawa T, Nishizawa Y.
    Osteoporos Int; 2005 May 15; 16(5):501-9. PubMed ID: 15309383
    [Abstract] [Full Text] [Related]

  • 11. Bone mineral density measured by dual-energy x-ray absorptiometry and novel markers of bone formation and resorption in patients on antiepileptic drugs.
    Välimäki MJ, Tiihonen M, Laitinen K, Tähtelä R, Kärkkäinen M, Lamberg-Allardt C, Mäkelä P, Tunninen R.
    J Bone Miner Res; 1994 May 15; 9(5):631-7. PubMed ID: 8053391
    [Abstract] [Full Text] [Related]

  • 12. Correlation between parathyroid hormone, bone alkaline phosphatase and N-telopeptide of type 1 collagen in diabetic and non-diabetic haemodialysis patients.
    Takahashi N, Kojima T, Ogawa H, Ishiguro N.
    Nephrology (Carlton); 2007 Dec 15; 12(6):539-45. PubMed ID: 17995578
    [Abstract] [Full Text] [Related]

  • 13. The clinical significance of serum osteocalcin and N-terminal propeptide of type I collagen in predialysis patients with chronic renal failure.
    Tsuchida T, Ishimura E, Miki T, Matsumoto N, Naka H, Jono S, Inaba M, Nishizawa Y.
    Osteoporos Int; 2005 Feb 15; 16(2):172-9. PubMed ID: 15164161
    [Abstract] [Full Text] [Related]

  • 14. Role of vitamin D and parathyroid hormone in the regulation of bone turnover and bone mass in men: the MINOS study.
    Szulc P, Munoz F, Marchand F, Chapuy MC, Delmas PD.
    Calcif Tissue Int; 2003 Dec 15; 73(6):520-30. PubMed ID: 12958693
    [Abstract] [Full Text] [Related]

  • 15. Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
    Inaba M, Nagasue K, Okuno S, Ueda M, Kumeda Y, Imanishi Y, Shoji T, Ishimura E, Ohta T, Nakatani T, Kim M, Nishizawa Y.
    Am J Kidney Dis; 2002 Jun 15; 39(6):1261-9. PubMed ID: 12046040
    [Abstract] [Full Text] [Related]

  • 16. Influence of sevelamer hydrochloride on serum concentration of whole (1-84) and N-terminally truncated (7-84) parathyroid hormone fragments in hemodialysis uremic patients.
    Chudek J, Piecha G, Kokot F, Wiecek A.
    J Nephrol; 2003 Jun 15; 16(5):710-5. PubMed ID: 14733418
    [Abstract] [Full Text] [Related]

  • 17. Relationship between bone formation markers bone alkaline phosphatase, osteocalcin and amino-terminal propeptide of type I collagen and bone mineral density in elderly men. Preliminary results.
    Lumachi F, Orlando R, Fallo F, Basso SM.
    In Vivo; 2012 Jun 15; 26(6):1041-4. PubMed ID: 23160690
    [Abstract] [Full Text] [Related]

  • 18. Discriminative value of biochemical markers of bone turnover in assessing the activity of Paget's disease.
    Alvarez L, Guañabens N, Peris P, Monegal A, Bedini JL, Deulofeu R, Martinez de Osaba MJ, Muñoz-Gomez J, Rivera-Fillat F, Ballesta AM.
    J Bone Miner Res; 1995 Mar 15; 10(3):458-65. PubMed ID: 7785468
    [Abstract] [Full Text] [Related]

  • 19. Metabolic gaps in bone formation may be a novel marker to monitor the osseous metastasis of prostate cancer.
    Koizumi M, Yonese J, Fukui I, Ogata E.
    J Urol; 2002 Apr 15; 167(4):1863-6. PubMed ID: 11912449
    [Abstract] [Full Text] [Related]

  • 20. Role of type I collagen C telopeptide, bone-specific alkaline phosphatase and osteocalcin in the assessment of bone status in postmenopausal women.
    Trento LK, Pietropolli A, Ticconi C, Gravotta E, De Martino MU, Fabbri A, Piccione E.
    J Obstet Gynaecol Res; 2009 Feb 15; 35(1):152-9. PubMed ID: 19215563
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.